Add to ORKGAbstract Osteogenesis imperfecta is a hereditary disorder of connective tissues characterised by low bone mass and bone fragility. Previous studies demonstrated that cyclical pamidronate therapy is effective in increasing bone density and improving clinical outcomes in children with osteogenesis imperfecta. We report our experience in treating two children with cyclical intravenous pamidronate infusion. The benefits and problems of the treatment are discussed. Key words Osteogenesis imperfecta; Paediatric; Pamidronate treatmen
Aim: To find an effective symptomatic treatment for osteogenesis imperfecta (OI). Methods: In a pros...
Involutional osteoporosis (OP), Osteogenesis imperfecta (OI) and Reflex sympathetic dystrophy syndro...
Background: Osteogenesis imperfecta (OI) is a group of genetic diseases with a wide spectrum of seve...
Severe osteogenesis imperfecta (OI) is a hereditary disorder char-acterized by increased bone fragil...
Osteogenesis imperfecta is a genetic disorder of extracellular matrix, characterized with decreased ...
Abstract Intravenous treatment with pamidronate is beneficial in children and adolescents with moder...
ABSTRACT: This analysis of 50 growing patients with osteogenesis imperfecta revealed that 2–4 years ...
WOS: 000238794300006PubMed ID: 16848111Different therapy models have been tried in order to decrease...
OBJECTIVE: Evaluate clinical outcome of early cyclic intravenous pamidronate treatment in children w...
Background: Patients with severe osteogenesis imperfecta (01; MIM number 259420) suffer from low bon...
Abstract Cyclical intravenous treatment with pamidro-nate is widely used to treat osteogenesis imper...
BackgroundPatients with severe osteogenesis imperfecta (OI; MIM number 259420) suffer from low bone ...
Pamidronate (PAM) infusion is the standard treatment in children with osteogenesis imperfecta (OI). ...
Abstract Treatment of moderate and severe forms of osteogenesis imperfecta (OI) with cyclic pamidron...
The appearance of this radiograph caused considerable concern in the casualty department. It shows t...
Aim: To find an effective symptomatic treatment for osteogenesis imperfecta (OI). Methods: In a pros...
Involutional osteoporosis (OP), Osteogenesis imperfecta (OI) and Reflex sympathetic dystrophy syndro...
Background: Osteogenesis imperfecta (OI) is a group of genetic diseases with a wide spectrum of seve...
Severe osteogenesis imperfecta (OI) is a hereditary disorder char-acterized by increased bone fragil...
Osteogenesis imperfecta is a genetic disorder of extracellular matrix, characterized with decreased ...
Abstract Intravenous treatment with pamidronate is beneficial in children and adolescents with moder...
ABSTRACT: This analysis of 50 growing patients with osteogenesis imperfecta revealed that 2–4 years ...
WOS: 000238794300006PubMed ID: 16848111Different therapy models have been tried in order to decrease...
OBJECTIVE: Evaluate clinical outcome of early cyclic intravenous pamidronate treatment in children w...
Background: Patients with severe osteogenesis imperfecta (01; MIM number 259420) suffer from low bon...
Abstract Cyclical intravenous treatment with pamidro-nate is widely used to treat osteogenesis imper...
BackgroundPatients with severe osteogenesis imperfecta (OI; MIM number 259420) suffer from low bone ...
Pamidronate (PAM) infusion is the standard treatment in children with osteogenesis imperfecta (OI). ...
Abstract Treatment of moderate and severe forms of osteogenesis imperfecta (OI) with cyclic pamidron...
The appearance of this radiograph caused considerable concern in the casualty department. It shows t...
Aim: To find an effective symptomatic treatment for osteogenesis imperfecta (OI). Methods: In a pros...
Involutional osteoporosis (OP), Osteogenesis imperfecta (OI) and Reflex sympathetic dystrophy syndro...
Background: Osteogenesis imperfecta (OI) is a group of genetic diseases with a wide spectrum of seve...